Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization by Bizet, A. et al.
ARTICLE
Received 27 Feb 2015 | Accepted 17 Sep 2015 | Published 21 Oct 2015
Mutations in TRAF3IP1/IFT54 reveal a new role for
IFT proteins in microtubule stabilization
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Ciliopathies are a large group of clinically and genetically heterogeneous disorders caused by
defects in primary cilia. Here we identified mutations in TRAF3IP1 (TNF Receptor-Associated
Factor Interacting Protein 1) in eight patients from five families with nephronophthisis (NPH)
and retinal degeneration, two of the most common manifestations of ciliopathies. TRAF3IP1
encodes IFT54, a subunit of the IFT-B complex required for ciliogenesis. The identified
mutations result in mild ciliary defects in patients but also reveal an unexpected role of IFT54
as a negative regulator of microtubule stability via MAP4 (microtubule-associated protein 4).
Microtubule defects are associated with altered epithelialization/polarity in renal cells and
with pronephric cysts and microphthalmia in zebrafish embryos. Our findings highlight the
regulation of cytoplasmic microtubule dynamics as a role of the IFT54 protein beyond the
cilium, contributing to the development of NPH-related ciliopathies.
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N
ephronophthisis (NPH) is an autosomal-recessive
nephropathy characterized by massive interstitial fibrosis,
tubular basement membrane thickening and cyst forma-
tion, leading to end-stage renal disease (ESRD) during child-
hood1. NPH is a major manifestation of ciliopathies, a large group
of diseases caused by dysfunction of the primary cilium2. The
cilium is a microtubule-based organelle present at the surface of
almost all vertebrate cells, which senses flow changes and
mediates signalling pathways essential during development and
tissue homeostasis, such as Hedgehog, Wnt/PCP and cAMP/PKA
signalling. Intraflagellar transport (IFT) selects cargos at the base
of the cilium and transports axonemal components required for
cilia assembly, and proteins involved in ciliary signalling. The
IFT-B complex, which consists of 16 different proteins, mediates
anterograde transport by associating with kinesin II and has been
shown to be essential for cilium formation3,4. Retrograde
transport is mediated by dynein 2 and the 6 subunits of the
IFT-A complex, however, inactivation of most IFT-A subunits
does not lead to major defects in ciliogenesis3,5.
NPH and associated syndromes are clinically and genetically
heterogeneous diseases. To date, NPH-causing mutations have
been identified in more than 20 genes (NPHP1–19;IFT140)6–8,
accounting for about 50% of all cases presenting with NPH9.
Most of the NPHP-encoded proteins participate in ciliary
function, either at the transition zone or as components of the
IFT complex. All 6 IFT-A subunit encoding genes are frequently
mutated in syndromic NPH, whereas mutations in only one IFT-
B encoding gene, IFT172, have been detected so far8,10.
TRAF3IP1 encodes the IFT-B subunit, IFT54, and its
inactivation is embryonic lethal and causes characteristic
ciliopathy phenotypes, including neural developmental defects,
polydactyly and microphthalmia in mice11, and curved body axis,
pronephric cysts and retinal degeneration in the elipsa zebrafish
mutant12,13.
Our study demonstrates that hypomorphic mutations in the
IFT-B protein IFT54 cause NPH with extrarenal defects. We
linked these mutations with mechanistic features previously
reported for other ciliopathies, including decreased ciliary cAMP
signalling, hyperacetylation of cytoplasmic microtubules and
defects in the establishment of cell junctions and polarity. Most
importantly, this work describes an extra-ciliary role of the IFT54
protein in the regulation of cytoplasmic microtubule dynamics by
modulating expression of MAP4. These data highlight a putative
new mechanism responsible for NPH and associated phenotypes.
Results
Identification of TRAF3IP1 mutations in NPH patients. Link-
age analysis combined with whole-exome sequencing (WES) in
parallel to targeted exome sequencing (‘ciliome’)6,10,14 conducted
in 1,427 individuals with NPH revealed mutations in TRAF3IP1
in eight individuals from five unrelated families (Table 1 and
Supplementary Fig. 1a–g and Supplementary Tables 1 and 2).
Three families carried three different homozygous missense
mutations, whereas in one family, the affected individual
NPH683–21 was compound heterozygous for a missense and a
stop codon mutation (Table 1 and Supplementary Fig. 1a–d).
Last, we identified a homozygous mutation in individual
NPH1110-22 that creates a new donor splice site after exon 13,
leading to a premature stop codon causing mRNA decay
(Supplementary Figs 1e and 2a–d). All missense mutations were
predicted to be damaging by Polyphen2, SIFT and/or PHRED2
(Table 1). Segregation of TRAF3IP1 mutations with the disease
was confirmed by Sanger sequencing in all families
(Supplementary Fig. 1a–e).
All of these patients presented with tubulointerstitial nephritis
characteristic of NPH (leading to ESRD between 3 and 16 years).
Microscopic analyses of kidney sections revealed massive
interstitial fibrosis with inflammatory cell infiltration, atrophic
tubules with thickening of the basement membrane, dediffer-
entiated tubules as well as dilatation of proximal tubules (Table 1,
Fig. 1a–c). Consistent with Senior–Løken Syndrome, all patients
with renal manifestation also developed early to late onset retinal
dystrophy (between 2 months and 20 years) with infrequent
occurrences of macular degeneration, nystagmus and strabismus
(Table 1; Fig. 1d; Supplementary Fig. 3). Four patients also
presented with liver defects (cholestasis, hepatic fibrosis or Caroli
disease) and six with skeletal anomalies (polydactyly, micro-
dactyly, small femoral heads; Table 1; Fig. 1e). Two patients from
family NPH579 presented with clinical features of Bardet–Biedl
Syndrome, i.e., developmental delay, retinal degeneration,
polydactyly, obesity and hypogonadism (Table 1). These multi-
systemic defects are reminiscent of mutations in the IFT172
gene10,15, although certain features, namely the retinal, hepatic
and skeletal defects, are also found with mutations in IFT-A
genes16,17.
The identified pathogenic mutations localize either at the
beginning of the C-terminal coiled-coil domain, known to bind
IFT20, another component of the IFT-B complex, or at the
N-terminal domain, within the calponin homology (CH) domain,
involved in tubulin binding18 (Fig. 1f). As most patients carried
either two missense mutations, a missense mutation in
association with a truncating mutation or an alternative splice
mutation giving rise to partial mRNA decay, it is likely that the
function of the protein is partly preserved. Indeed, the
phenotypes observed in the patients bearing TRAF3IP1
mutations somewhat reconcile the organ involvement of loss-
of-function animal models, but the milder phenotypes observed
suggest that the identified mutations are hypomorphic.
In vivo analysis of TRAF3IP1 mutations in zebrafish. To con-
firm the pathogenicity of the identified TRAF3IP1 mutations, we
injected wild type (WT) and mutated mRNA into both elipsa
mutant and traf3ip1 morphant zebrafish embryos. While injec-
tion of WT mRNA resulted in a partial rescue of the mutant
phenotypes, injection of mutated mRNA constructs mimicking
the human mutations could not rescue the curved body axis,
glomerular cysts, dilated pronephric tubules, oval eye shape and
loss of photoreceptors and even led to an exacerbation of the
ocular phenotype (Fig. 2a–f, Supplementary Fig. 4a–f). Notably,
the most consistently severe phenotypes observed were those
arising from injections with the construct mimicking the p.R155*
(p.R154* in zebrafish), as could be expected for a truncating
mutation (Fig. 2a–f, Supplementary Fig. 4a–f). These data further
prove that mutations in TRAF3IP1 are causal for NPH and retinal
degeneration.
TRAF3IP1 mutations result in ciliary localization defects.
Having validated the damaging effects of the mutations in vivo,
we next analysed their consequences on the localization of IFT54
within the cilia and on ciliogenesis. This study was conducted
in several in vitro models, including patients’ fibroblasts and
Traf3ip1 knock-down (KD) mIMCD3 cells re-expressing either
WT or mutant forms tagged with green fluorescent protein (GFP;
Supplementary Fig. 5a,b).
GFP–IFT54–WT was found at the base and at the tip of cilia
when transfected into fibroblasts and KD mIMCD3 cells (Fig. 3a,
Supplementary Fig. 5c). This localization was confirmed using a
commercial anti-IFT54 antibody that specifically recognizes the
human form of IFT54 (Fig. 3a, Supplementary Fig. 5b). Next, we
investigated the precise localization of IFT54 at the base of cilia.
It has been shown previously that IFT54 docks to the transition
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fibres through its interaction with FBF1 (ref. 19). As expected,
IFT54 was present at the ciliary transition fibres/transition zone,
based on its co-localization with the distal appendage protein
Cep164 (Fig. 3b). In addition, it co-localized with g-tubulin at the
proximal part of the centrioles (Fig. 3e, Supplementary Fig. 5c).
Remarkably, endogenous IFT54 in patients’ fibroblasts and IFT54
mutant forms expressed in KD mIMCD3 cells were absent from
the transition zone and from the tip of cilia (Fig. 3c–g,
Supplementary Fig. 5c), indicating that the mutations impair
entry of IFT54 into the ciliary compartment.
Therefore, we assessed the effects of TRAF3IP1 mutations on
ciliogenesis in fibroblasts from patients. While there was no
difference in the percentage of ciliated cells, cilia were
significantly longer (Supplementary Fig. 6a–c). Consistently, the
defects in ciliogenesis observed in Traf3ip1-depleted zebrafish
embryos and mIMCD3-KD cells were partially rescued by re-
expression of IFT54 mutants, except p.R155* (Supplementary
Figs 4g and 5d). This suggests that the observed phenotype in
patients as well as in zebrafish may not be caused by defects in
ciliogenesis per se.
Moreover, in the cilia formed in patients’ fibroblasts, there was
no obvious change in the localization of key ciliary proteins
(IFT46, IFT140, Anks6 and Smoothened; Supplementary Fig. 6d–g),
suggesting no general defect in ciliary composition and
trafficking. However, we noticed a clear decrease of adenylyl
cyclase III (ACIII) staining in cilia (Supplementary Fig. 7a,b).
This defect in ACIII localization was associated with impaired
translocation of PKA catalytic subunits from the cilium base to
the cytoplasm on treatment with forskolin, an AC activator
(Supplementary Fig. 7c,d). This result links IFT54 to the
regulation of the cAMP/PKA pathway, as observed for mutations
in IFT172 (ref. 10). Nevertheless, the mild ciliary structural
defects associated with hypomorphic mutations of TRAF3IP1
seem insufficient to account for the large phenotypic spectrum of
the patients and suggest that IFT54 may have an important
extraciliary function.
N-terminal mutations of TRAF3IP1 impair binding to MAP4.
To gain insight into the underlying mechanism responsible for
the deleterious effects of TRAF3IP1 mutations, we studied the
impact of these mutations on known IFT54 interacting partners.
IFT54 forms a peripheral IFT-B sub-complex through the
interaction of its C-terminal coiled-coil domain with IFT20
(ref. 20). In contrast to the two truncating alleles (p. R155* and
p.M525Mfs3*), the missense mutations, including the C-terminal
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p.M520R, had little or no impact on IFT20 binding, indicating
that the IFT54–IFT20 sub-complex is preserved in most patients
(Supplementary Fig. 8a).
The majority of the identified mutations are present in the
N-terminal CH-domain, previously shown to be involved in the
interaction with a-tubulin and potentially other cargoes for IFT
transport18. Computational modelling of the N-terminal p.I17S
and p.V125M/p.V125A substitutions predicted a disruption
of two hydrophobic pockets of the CH domain (Fig. 4a).
Consistently, introduction of the p.I17S or p.V125A/M
mutations in this isolated CH-domain (1–133) generated
insoluble (likely unfolded) recombinant proteins (Supplementary
Fig. 8b–d). Moreover, circular dichroism and thermal
denaturation experiments, using full-length IFT54 in complex
with IFT20 (Supplementary Fig. 8e), indicated that the CH
domain of the IFT54 mutants is not accurately folded at 37 C,
likely affecting IFT54 binding to a-tubulin in vivo (Table 2).
Indeed, IFT54 can be found along cytoplasmic microtubules21,22
and we observed that structural defects incurred by N-terminal
mutations effectively impaired this localization (Supplementary
Fig. 9). Altogether, these data indicate that the N-terminal
mutations affect the stability of the CH domain of IFT54 and
therefore inhibit its ability to bind to tubulin and/or other
partners.
Among several previously identified candidate partners of
IFT54 (ref. 18), we found that N-terminal mutations
predominantly impaired the interaction with MAP4, while WT
or the p.R155* mutant display normal interactions (Fig. 4b).
MAP4 is the major MAP in non-neuronal cells23 that stabilizes
cytoplasmic microtubules24. MAP4 is also known to localize into
primary cilia where it acts as a negative regulator of ciliary length,
counteracting the function of septins25. Consistently, we found
that ciliary MAP4 staining was drastically reduced in patients’
fibroblasts (Fig. 4c,d) suggesting that loss of interaction between
MAP4 and IFT54 in N-terminal mutants results in ciliary
mislocalization. This result indicates that MAP4 could be a cargo
of IFT54 for ciliary import.
TRAF3IP1 mutations affect cytoplasmic microtubule dynamics.
MAP4 is well known to bind to cytoplasmic microtubules and
regulate their stability, so we analysed if TRAF3IP1 mutations
could disturb MAP4 localization and expression. Unexpectedly,
MAP4 staining was strongly increased along cytoplasmic micro-
tubules in mutant cells (Supplementary Fig. 10a), which correlates
with an overall enhanced protein expression (Fig. 5a,b,
Supplementary Fig. 10b–d). As MAP4 mRNA remained
unchanged in mutant conditions (Supplementary Fig. 10e), it is
likely that IFT54 regulates MAP4 protein stability. Hence,
mutations in TRAF3IP1 increase MAP4 expression and its
recruitment to microtubules, which in turn is expected to result in
their stabilization24.
We thus investigated whether TRAF3IP1 mutations could
affect cytoplasmic microtubule dynamics, by first assessing the
level of acetylated a-tubulin, a marker of stable microtubules26.
Hyperacetylation of a-tubulin was observed in mutant fibroblasts
(Fig. 5c), as well as in Traf3ip1-KD mIMCD3 cells, and was
restored by re-expression of IFT54-WT but not by the mutant
forms (Supplementary Fig. 11a). In patients’ kidney tubules, the
increase in a-tubulin acetylation correlated with enhanced MAP4
levels (Fig. 5d), indicating that in vivo, tubular lesions are
associated with microtubule stabilization. We then evaluated the
impact of TRAF3IP1 mutations on the resistance of microtubules
to cold treatment, which induces their depolymerization.
Microtubules positive for MAP4 and resistant to cold treatment
were detected in fibroblasts and mIMCD3 mutant cells (Fig. 5e,
Supplementary Fig. 11b), consistent with increased microtubule
stability. Finally, we examined the level of EB1 staining at the
microtubule plus-tips, which reflects the dynamics of growing
ends of microtubules27. EB1 staining at the plus-tips of
microtubules was drastically reduced in mutant fibroblasts
(Fig. 5f), mimicking the overexpression of GFP-MAP4 in
control fibroblasts (Supplementary Fig. 12a). Altogether, these
results demonstrate that mutant cells display an abnormal
stability of cytoplasmic microtubules that is linked to the
increased expression of MAP4.
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Figure 1 | Identification of TRAF3IP1 mutations in patients with nephronophthisis and retinal degeneration. Periodic acid schiff (a), trichrome (b) and
silver methenamine (c) staining on kidney sections from individual NPH302-23 (a,b) and NPH1110-22 (c) revealed massive interstitial fibrosis (arrow
heads) with cell infiltration, atrophic tubules with thickening of the basement membrane (arrows), as well as dilatation of proximal tubules (asterisks),
characteristic of NPH. Scale bar, 50mm. (d) Fundus photograph of individual NPH1110-22 showed characteristic aspects of RP, with pigmentary
reorganization, papillary pallor and thin retinal vessels. (e) Left hand X-ray of individual NPH1110-22 showing short fingers (brachydactyly). (f) Organization
of exons of TRAF3IP1 cDNA (top panel) and functional domains of IFT54 protein with an N-terminal calponin homology (CH) domain involved in tubulin
binding, an Arginine-rich motif and a C-terminal coiled-coil domain involved in IFT20 binding. Black bars indicate positions of the identified mutations.
Family numbers are underlined. H, homozygous; h, heterozygous.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9666
4 NATURE COMMUNICATIONS | 6:8666 | DOI: 10.1038/ncomms9666 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
To further confirm these observations, we studied the
consequences of Traf3ip1 mutation on microtubule dynamics
in vivo, using an EB3-GFP fusion construct as a reporter of
plus-tip dynamics in elipsa mutant and WT zebrafish. Mutant
embryos displayed a significantly lower speed of EB3 comets,
confirming slower rates of microtubule polymerization compared
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Figure 2 | Patients mutations do not rescue the ciliopathy-associated phenotypes characteristic of elipsa mutants. (a) Lateral views of zebrafish
larvae at 72 hpf of WTcontrol, elipsa uninjected larvae and elipsa larvae injected with WTor mutant RNA constructs (p.R154* and p.V459R correspond to
the human p.R155* and p.M520R mutations, respectively). Approximately 20% of V125M-injected elipsa larvae displayed an alternative stunted phenotype
with pronephric cysts and eye defects, but lacking the characteristic body axis curvature. Scale bar, 0.5mm. (b) Phenotype distribution as determined by
quantification of angle of body axis curvature (nZ30, 4 independent experiments). (c) Eye phenotypes (5 dpf) of WTcontrol, elipsa uninjected larvae and
elipsa larvae injected with WT/mutant RNA constructs, lateral views, anterior to the left. Scale bar, 0.1mm. (d) Surface area of the retina (mean± s.d. of
n¼ 10, 2 independent experiments, *P¼0.05, **Po0.01, and ***Po0.001, Dunnett’s multiple-comparison test). (e) H&E staining of histological cross
sections of elipsa mutant larvae injected with WT or mutant RNA constructs at 72 hpf. Gross cystic dilations of the glomerular region extending to the
pronephric tubule are indicated by asterisks. Scale bar, 20mm. (f) Percentage of pronephric cysts in elipsa mutant larvae as well as rescued larvae (nZ30,
4 independent experiments).
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Figure 3 | Mutations of TRAF3IP1 impair IFT54 ciliary trafficking. (a) Fibroblasts transfected with GFP–IFT54-WTwere fixed with MeOH and stained for
GFP (green), IFT54 (red) and acetylated a-tubulin (blue, cilia). The base and the tip of the cilia are indicated by arrowhead and asterisk respectively. Scale
bar, 1mm. (b) Traf3ip1-KD mIMCD3 cells stably expressing GFP-tagged IFT54 WTwere fixed with 4% PFA and stained for Cep164 (distal appendages, red).
Scale bar, 1mm. (c) Ciliary distribution of IFT54 in serum-starved control and patients’ fibroblasts stained for IFT54 (red), acetylated a-tubulin (green, cilia)
and the basal body marker g-tubulin (blue). Scale bar, 1mm. (d) Percentage of cilia with IFT54 at the distal tip of cilia (arrows in (c), mean± s.e.m. of n¼4
experiments (that is, E100 cilia), ***Po0.001, Bonferronni’s multiple-comparison test). (e) Distribution of IFT54 at the basal body in ciliated fibroblasts
stained for IFT54 (red) and for g-tubulin (blue) and centrin (green), markers of proximal and distal parts of centrioles, respectively. A schematic
representation of the orientation of the two centrioles, with the localization of the distal (DAP) and subdistal (sDAP) appendages is shown. Scale bar, 1mm.
(f) Intensity of IFT54 staining at the transition fibres/transition zone (TZ, arrows in (e), mean ± s.e.m. of n¼ 3 experiments (that is, E50 cilia),
***Po0.001, Dunn’s post-hoc test). (g) Fibroblasts from control or affected individuals were fixed and stained for ODF2 (red, subdistal appendages) and
IFT54 (green) and analysed by STED microscopy. A schematic representation of the orientation of the analysed centrioles is shown. Arrows in g indicate
the pool of IFT54 present at the distal tip of the mother centriole corresponding to the transition fibers/transition zone. Scale bars, 0.25mm.
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with heterozygous control siblings (Fig. 5g,h). Altogether,
these data emphasize a novel role for IFT54 as a negative
regulator of microtubule stability, likely through the regulation of
MAP4.
IFT54 is required for correct epithelial morphogenesis.
Microtubule network architecture is crucial for epithelial
integrity28,29, hence we investigated the impact of TRAF3IP1
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Figure 4 | TRAF3IP1 mutations impair folding of the CH domain and interaction with MAP4. (a) Crystal structure of the CH domain of MmIFT54
(based on PDB entry 2EQO) showing that the I17 and V125 residues locate in conserved hydrophobic pockets (dotted line circles). The mutant residues
S17, A125 and M125 were introduced (red) to show their effects on these hydrophobic pockets. (b) Lysates from HEK293Tcells co-expressing Flag-tagged
WT or mutant forms of MmIFT54 (p.K155*, p.I453R and p.M458Mfs3* correspond to the human mutations p.R155*, p.M520R and p.M525Mfs3*)
and GFP-MAP4 were immunoprecipitated with an anti-GFP antibody. The co-immunoprecipitation of GFP-MAP4 and Flag-IFT54 constructs was
followed by western blot (WB) using GFP and Flag antibodies. (c) Serum-starved fibroblasts were fixed in PFA to visualize ciliary MAP4 (red; acetylated
a-tubulin, green). Scale bar, 2 mm. (d) Intensity of ciliary MAP4 staining (mean± s.e.m. of n¼ 5 experiments (that isE150 cilia, *Po0.05, ***Po0.001,
Dunn’s post-hoc test).
Table 2 | TRAF3IP1 N-terminal mutations result in lower stability of the IFT54/IFT20 complex.
Sample Secondary structure determination Thermal unfolding
a (%) b (%) Turn (%) Unstructured (%) Melting temperature TM (C, ± s.d.)
CrIFT54-WT/CrIFT20 46 9 16 29 51.15±0.040
CrIFT54-V126A/CrIFT20 39 11 19 31 48.75±0.061
CrIFT54-V126M/CrIFT20 35 16 18 31 48.15±0.106
CrIFT20 71 1 6 22 41.62±0.146
Secondary structure determination and thermal unfolding using circular dichroism spectroscopy for WTas well as p.V126A and p.V126M mutants of CrIFT54 (corresponding to the human p.V125A and
p.V125M mutations) in complex with CrIFT20.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9666 ARTICLE
NATURE COMMUNICATIONS | 6:8666 | DOI: 10.1038/ncomms9666 | www.nature.com/naturecommunications 7
& 2015 Macmillan Publishers Limited. All rights reserved.
appeared disorganized in polarized Traf3ip1-KD mIMCD3 cells,
and was restored by re-expression of IFT54-WT but not by IFT54
mutants (Supplementary Fig. 11c). The reformation of tight
junctions and cell polarity were assessed by trans-epithelial
resistance (TER) measurement following Ca2þ switch
(Fig. 6a–d). Traf3ip1-KD cells presented a decreased TER and
reduced b-catenin localization at cell junctions, both of which
were partially rescued by re-expression of WT and the p.V125M
mutant but not by the p.R155* or p.M520R mutants (Fig. 6a,b).
In addition, Traf3ip1-KD cells and all cells re-expressing
IFT54-mutant proteins appeared flatter than controls and
displayed decreased expression of the apical marker Gp135
(Fig. 6a,c,d). These results suggest that IFT54 mutant proteins
may perturb the establishment of cell junctions and/or the
targeting of apical proteins during epithelialization, as we
previously reported for NPHP1 and NPHP4 (ref. 30).
To further study epithelialization and polarity processes, we
used a well-established three-dimensional (3D) spheroid culture
system that reflects the biology of kidney tubular epithelial cells.
When cultured in matrigel, mIMCD3 control cells formed
single-lumen spheroids, whereas Traf3ip1-KD cells formed
abnormal structures with small lumens filled with dividing cells
and/or surrounding misarranged nuclei, with markedly altered
expression of the tight-junction component ZO1 (Fig. 6e,f).
Normal lumen formation and ZO1 localization were restored by






































































































































































Figure 5 | Mutations of TRAF3IP1 increase MAP4 expression, causing cytoplasmic microtubule stabilization. (a) Expression of MAP4 and GAPDH in
control and patients’ fibroblasts were analysed by WB. (b) Relative expression of MAP4 normalized to that of GAPDH (mean ± s.e.m. of n¼ 5
experiments, *Po0.05, Dunn’s post-hoc test). (c) Fibroblasts were stained for acetylated a-tubulin (green). Scale bar, 10mm. (d) Kidney biopsies from
control and NPH638-21 and NPH302-23 affected individuals were stained for MAP4 (red), acetylated a-tubulin (green) and with peanut agglutinin (PNA,
light blue, distal tubules). Scale bar, 25mm. (e) Fibroblasts treated for 10min on ice (to depolymerize the microtubules) were fixed with MeOH (to visualize
MAP4 on microtubules) and stained for a-tubulin (green), g-tubulin (light blue) and MAP4 (red). Scale bar, 10mm. (f) Fibroblasts were stained for
a-tubulin (green) and the microtubule plus-tip associated protein EB1 (red). Scale bar, 2 mm. (g) WT and elipsa embryos were injected with EB3-GFP to
follow the dynamics of the growing ends of microtubules which were analysed by time lapse confocal microscopy and Imaris tracking software. Pseudo
colours were used to visualize the speed of EB3 comets (from blue (slow) to red (fast)). (h) Track speed analysis of EB3-GFP comets in WT and elipsa
embryos (n¼6, mean ± s.d., ***Po0.001, t-test).
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proteins (Fig. 6e,f). These results demonstrate that in addition to
its known function in ciliogenesis, IFT54 plays a key role in the
early steps of epithelial morphogenesis, a process independent
of cilia31.
Decreased MAP4 expression rescues TRAF3IP1 mutation
defects. Our data suggest that the epithelialization defects asso-
ciated with TRAF3IP1 mutations are mediated by the observed
attendant increase in cytoplasmic MAP4 expression and micro-
tubule stability. To validate this hypothesis, we first studied the
consequences of overexpression of MAP4. A stable cell line
overexpressing MAP4 displayed microtubule hyperacetylation
and defects in cell-polarity establishment, associated with a loss of
the apical marker Gp135 and of b-catenin at the cell junctions
(Supplementary Fig. 12b–d). Finally, MAP4 overexpressing cells
formed abnormal 3D structures with no lumens (Supplementary
Fig. 12e). Thus, increased levels of MAP4 expression recapitulates
the epithelialization and polarity defects observed in Traf3ip1
mutant cells.
To provide further evidence that TRAF3IP1-related defects
were mediated by MAP4, map4 was knocked down in zebrafish
using morpholinos. Loss of MAP4 results in very high mortality
rates, severe ventralization or curved body axis phenotypes in the
vast majority of WT embryos (470%) (Fig. 7a). In contrast, a
much smaller proportion (420%) of elipsa embryos are fatally
affected by loss of MAP4. More strikingly, 40% of map4-KD
elipsa embryos showed a reduction in the severity of the curved
body axis phenotype at 48 hpf and almost a third showed no
increase in severity of phenotype (Fig. 7b). A 5-base-pair
mismatch control morpholino had no effect on490% of injected
elipsa embryos or WT siblings (Fig. 7a,b). Therefore, our results
indicate that the elipsa phenotype is partially induced through
dysregulation of MAP4 expression.
We next inactivated Map4 by shRNA in mIMCD3 Traf3ip1-
KD cells (Fig. 7c). The decreased expression of MAP4 in
Traf3ip1-KD cells and in cells re-expressing the mutants reduced
microtubule acetylation to a level similar to that of control cells
(Fig. 7d). In addition, knocking down Map4 rescued Gp135
expression in both Traf3ip1-KD cells and in cells re-expressing
the mutants (Fig. 7e). Finally, Map4-KD partially restored the
formation of normal spheroids in Traf3ip1-KD cells, and in cells
re-expressing the mutant forms of IFT54 (Fig. 7f). Overall these
results show that normalization of MAP4 overexpression can
rescue to a large extent the cellular phenotype observed in
Traf3ip1-KD cells. It is noteworthy that depletion of MAP4 in
control cells caused abnormal sphere formation similar to that
seen when overexpressing MAP4 and mirroring our observations
in WT zebrafish. This suggests that precise regulation of MAP4
expression level is essential for correct epithelialization of kidney
collecting duct cells.
Altogether, these results demonstrate that TRAF3IP1 muta-
tions lead to abnormal microtubule dynamics and altered cell
polarity, via defective regulation of MAP4.
Discussion
In this work, we have identified mutations of TRAF3IP1 as a
cause of NPH and retinal degeneration, associated with liver
fibrosis, skeletal abnormalities and obesity. We thus propose
NPHP20 as an alias for TRAF3IP1. Of the sixteen IFT-B
components, IFT54 is only the fourth component demonstrated
to be causative of human ciliopathies. Previous loss-of-function
studies have also shown the importance of this anterograde IFT
subunit, as loss of Traf3ip1 is embryonic lethal with attendant
neural, skeletal and ocular defects in mice, and loss of cilia, retinal
degeneration, body axis curvature and pronephric cysts in elipsa
mutant zebrafish11–13.
Although IFT54 has been shown to be required for ciliogenesis,
the patients’ mutations identified in this study do not impair cilia
formation. This is indicative of a hypomorphic effect of these
mutations, that may explain the milder phenotype observed in
patients compared with loss-of-function animal models. Analysis
of ciliary composition from mutant fibroblasts did not reveal
major defects, except for ACIII, which was strongly decreased and
associated with a defective cAMP/PKA pathway. Defective
cAMP/PKA signalling is a common feature of mutations in IFT
genes10,32 and provides a potential explanation for the obesity
observed in patients, a characteristic of an ACIII-deficient murine
model33. It could also explain the increased cilia length observed
in patient fibroblasts, as the ACIII–cAMP pathway has been
linked to cilia length regulation34.
Because of this relatively mild phenotype, we investigated
additional potential cargoes of IFT54 that could be affected by the
identified hypomorphic mutations. After screening a large
number of candidates from literature, we demonstrated that
N-terminal mutations of TRAF3IP1 abrogate the interaction with
MAP4 and suppress its ciliary entry, suggesting MAP4 as a cargo
for IFT54. Since we have previously described MAP4 as a negative
regulator of ciliogenesis25, the decreased ciliary expression of
MAP4 may also be linked to the increased cilia length observed in
patients’ fibroblasts.
Most surprisingly, although the level of ciliary MAP4 protein
is decreased, we observed a strong increase in MAP4 staining
along cytoplasmic microtubules coupled with an overall increase
in protein expression. Thus it seems that IFT54 negatively
regulates MAP4 protein levels and may inhibit recruitment of
MAP4 to the microtubules, a process known to induce
microtubule stabilization24. Indeed, in both our in vivo and
in vitro models, we observed that mutations in TRAF3IP1 result
in increased stabilization of microtubules. These defects in
microtubule dynamics were associated with loss of apico-basal
polarity in epithelialized kidney cells. Importantly, overexpression
of MAP4 reproduces similar cellular defects while knock-down of
Map4 rescues TRAF3IP1 mutations for most of the cellular
phenotypes observed, demonstrating that IFT54 plays a role
outside the cilia, by modulating MAP4 levels and thereby
regulating cytoplasmic microtubule dynamics and cell polarity
establishment/maintenance (Supplementary Fig. 13).
Although it is likely that IFT54 modulates MAP4 degradation,
the exact mechanism by which IFT54 regulates MAP4 remains to
be determined. As demonstrated for Septins23, it is possible that
IFT54 competes with MAP4 for binding to the microtubules.
Indeed, the association between the CH domain of IFT54 and
MAP4 could be indirect through microtubules. Thus, N-terminal
mutants of IFT54, which may have lower affinity for tubulin
(as indicated by their impaired localization to microtubules and
their unfolded CH domain), would increase the number of
available binding sites for MAP4 on microtubules. As a
consequence, MAP4 may be stabilized when bound to
microtubules, promoting its accumulation. On the other hand,
the p.M520R mutant still associates with microtubules and with
MAP4. However, introduction of this mutation leads to increased
MAP4 levels, suggesting the C-terminal domain of IFT54 may
recruit an additional player required for MAP4 degradation.
MAP4 has been shown to be phosphorylated by several
microtubule affinity-regulating kinases24 as well as by PKA,
resulting in MAP4 dissociation from the microtubules35. Thus,
the low PKA activity in mutant cells could also provide an
explanation for increased MAP4 levels along the microtubules.
By competing with Septin2, MAP4 has been shown to impair
the delivery of proteins from the Golgi to the plasma membrane,
a process required for the establishment of polarized/columnar
shape epithelia36. In a similar manner, IFT54 could play a role
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in the transport of membrane and junction proteins along the
microtubule network, with TRAF3IP1 mutations resulting in
mistargeting of Gp135 and b-catenin. The subsequent defect in
polarity establishment may lead to loss of differentiation and
progressive degeneration of the epithelium, thus explaining











































































































































































































































Figure 6 | TRAF3IP1 mutations lead to epithelialization and polarity defects. (a) mIMCD3 cells grown until confluence on filters were subjected to
Ca2þ -free medium to disrupt the tight junctions. Six hours after Ca2þ addition, cells were analysed by immunofluorescence using the apical marker Gp135
(red) and b-catenin (light blue) to stain the cell junctions. Scale bar, 10mm. (b) Following Ca2þ switch, tight junction re-formation was assessed by
measurement of trans-epithelial resistance (TER) at different time points (mean ± s.e.m. of n¼ 5 independent experiments, two-way ANOVA;
NS: not-significant, ***Po0.001 at 6 h). (c) Height of mIMCD3 cells grown on filters measured as the distance from the base to the top of the cells
(GFP staining, not shown; mean± s.d. of nZ20, from 3 independent experiments, ***Po0.001, Bonferonni’s multiple-comparison test). (d) Expression of
the apical marker Gp135 was analysed by Western blot with a-tubulin as a loading control. (e) mIMCD3 cells grown in matrigel 3D matrix to form
spheroids were stained for ZO1 (tight junctions, red) and analysed by confocal microscopy. Arrows indicate ZO-1 at the apical junctions, while arrow heads
point to mislocalized ZO-1. Equatorial sections of representative spheres are shown for each cell line. Scale bars, 10mm. (f) Percentage of abnormal
spheroids (no/small lumen filled with cells) (mean ± s.d., n¼ 80 spheroids from 2 independent experiments, ***Pr0,001, **Po0.002, Bonferonni’s
multiple-comparison test).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9666
10 NATURE COMMUNICATIONS | 6:8666 | DOI: 10.1038/ncomms9666 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
degeneration and the development of hepatic fibrosis, common
progressive features of the so-called ‘ciliopathies’.
In the course of this study, we observed that decreased
MAP4 expression is deleterious for lumen formation in
3D-cultured control cells and is fatal to WT zebrafish embryos,
whereas it appears to have a partial rescue effect on Traf3ip1-KD
cells and elipsa mutants. In humans, MAP4 loss-of-function
mutations have recently been associated with Seckel syndrome
(microcephaly at birth, dwarfism, brachydactyly or cone-shaped
epiphyses)37. Conversely, we showed that overexpression of
MAP4 results in similar epithelialization phenotypes to
those observed in TRAF3IP1 mutant cells indicating that
TRAF3IP1-dependent increase of MAP4 expression results in
NPH, retinal degeneration and hepatic fibrosis. Therefore, fine
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Figure 7 | Defects in TRAF3IP1 mutants are mediated by MAP4. (a) Lateral views of WT zebrafish embryos injected with map4 morpholino at 48 hpf
and phenotype distribution in WT embryos injected with control or map4 morpholino. (b) Lateral views of elipsa zebrafish embryos injected
with map4 morpholino at 48 hpf and phenotype distribution in elipsa mutant embryos injected with control or map4 morpholino (data shown as combined
result of n¼ 3 independent experiments). Scale bars, 1mm. (c) Relative expression ofMap4 normalized to that of Hprt was analysed by qPCR in control and
Traf3ip1-KD mIMCD3 cells stably expressing GFP or GFP-IFT54 mutants and Map4 shRNA. (d) Control and Traf3ip1-KD/ Map4-KD mIMCD3 cells
expressing either GFP or IFT54-GFP fusions were fixed in MeOH and stained for acetylated a-tubulin (red) and g-tubulin (light blue).
Scale bar, 10mm. (e) Six hours after Ca2þ switch, mIMCD3 cells grown until confluence on filters were fixed with 4% PFA and stained for the apical
marker Gp135 (red). Scale bar, 10mm. (f) Percentage of normal spheroids of control and Traf3ip1-KD/ Map4-KD mIMCD3 cells expressing either GFP or
IFT54-GFP fusions grown on Matrigel for 5 days (mean± s.d., nZ100 spheroids from 3 independent experiments, ***Pr0,0001, *Po0.012, Bonferonni’s
multiple-comparison test).
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Taken together, our data highlight two not mutually exclusive
functions of IFT54: first, as a regulator of ciliary composition; and
second, as a negative regulator of cytoplasmic microtubule
stability via MAP4. Since other NPHPs have been reported
to localize along the cytoplasmic microtubule network, and
hyperacetylation remains an unexplained observation in several
ciliopathy models11,38–42, defective regulation of microtubule
dynamics may be a general pathophysiological mechanism
leading to diverse degenerative organ lesions, in particular
NPH. Further investigation is needed to establish whether
NPHPs share a common aetiology linked to MAP4 and ciliary
cAMP signalling as described in our study. Such understanding
could provide a new perspective for potential therapeutics for
ciliopathies.
Methods
Patients and families. Written informed consent was obtained for all individuals
enrolled in this study and approved by the Institutional Review boards at the
University of Paris Descartes and at the University of Michigan.
Homozygosity mapping, exome sequencing and mutation calling.
Homozygosity mapping in families NPH302 and A4336 was performed using
‘Human Mapping 250k NspI’ array and parametric logarithm of odds scores
were calculated with MERLIN software43 for NPH302, and GENEHUNTER 2.1
(ref. 44) ALLEGRO45 for A4336, assuming autosomal-recessive inheritance.
WES in patients A4336-22 and NPH302-23 were performed as follow. In brief,
genomic DNA was isolated from blood lymphocytes and subjected to exome
capture using Agilent SureSelect human exome capture arrays (Life Technologies)
followed by next generation sequencing on the Illumina sequencing platform.
Ciliary exome-targeted sequencing was conducted in NPH579-22, NPH638-21 and
NPH1110-22, using a custom SureSelect capture kit (Agilent Technologies)
targeting 4.5Mb of 20,168 exons (1 221 ciliary candidate genes), including
TRAF3IP1 (refs 14,46). Briefly, Agilent SureSelect librairies were prepared from
3 mg of 300 genomic DNA samples sheared with a Covaris S2 Ultrasonicator
according to manufacturer’s instructions. The SOLiD molecular barcodes for
traceable ID of samples were added at the end of the capture step. The Ovation
Ultralow System (NuGEN Technologies) was used to prepare HiSeq2500
precapture barcoded libraries. The ciliome capture by hybridization was performed
on a pool of 10 to 16 barcoded precapture libraries. Sequencing performed on
SOLiD5500XL (Life Technologies) and HiSeq2500 (Illumina) was done on pools of
barcoded ciliome libraries (64 barcoded ciliome libraries per SOLiD FlowChip and
16 ciliome libraries per lane of HiSeq FlowCell). Paired-end reads were generated
(75þ 35 for SOLiD, 100þ 100 for HiSeq) and sequences were aligned to the
reference human genome hg19 with Illumina’s processing software ELAND
(CASAVA 1.8.2), the Burrows–Wheeler Aligner (Illumina) or mapread (SoliD).
Downstream processing for WES in NPH302-23 and ciliome in NPH579-22,
NPH638-21 and NPH1110-22 was carried out with the Genome Analysis Toolkit
(GATK), SAMtools, and Picard Tools, following documented best practices (http://
www.broadinstitute.org/gatk/guide/topic?name=best-practices). All variants were
annotated using a software system developed by the Paris Descartes University
Bioinformatics platform47. The mean depth of coverage obtained was greater than
 90, and 489% of the exome was covered at least  15. Different filters were
applied to exclude all variants located in non-exonic regions, pseudogenes,
untranslated regions or known polymorphic variants with a frequency above 1%,
that is present in databases such as dbSNP, 1000 genome projects and all variants
identified by in-house exome sequencing (5,150 exomes and 1,020 ciliomes).
The functional consequence of missense variants was predicted using SIFT
(http://sift.jcvi.org/www/SIFT_enst_submit.html), CADD/PHRED2
(http://cadd.gs.washington.edu/) and PolyPhen2 software (http://genetics.bwh.
harvard.edu/pph2/). For A4336-22, SAMtools37 was used to call single-nucleotide
variants and insertion/deletion at targeted bases. Variants with minor allele
frequencies o1% in the Yale (1,972 European subjects), NHLBI GO Exome
Sequencing Project (4,300 European and 2,202 African American subjects), dbSNP
(version 135) or 1,000 Genomes (1,094 subjects of various ethnicities) databases
were selected and annotated for impact on the encoded protein and for
conservation of the reference base and amino acid among orthologs across
phylogeny. Sequence reads were mapped to the human reference genome assembly
(GRCh37/hg19) using CLC Genomics Workbench (version 4.7.2) software
(CLC bio, Aarhus, Denmark). Mutation calling was performed by geneticists/cell
biologists, who had knowledge of the clinical phenotypes and pedigree structure,
as well as experience with homozygosity mapping and exome evaluation, as in
Boyden et al.48
Sanger sequencing using the primers described in Supplementary Table 3 was
performed to validate the NGS findings and the segregation of the mutation within
all the families. To confirm segregation of the two heterozygous mutations (both
located on exon 4) carried by patient NPH638-2 and for which parental DNA was
not available, exon 4 was amplified by PCR and subcloned into a pGEM-T Easy
vector. Sequencing of the independent clones revealed that the mutations were
never found in the same PCR fragment, thus demonstrating that each of the
mutations were on a different allele.
Purification and pull down of recombinant proteins. Truncations of MmIFT54
containing the N-terminal CH domain (either WT or point mutations) were cloned
into bacterial pEC vectors with cleavable glutathione S-transferase or hexahistidine
tags using ligation-independent cloning. These pEC vectors were created at the
Department for Structural Cell Biology at the Max Planck Institute of Biochemistry
(details available on request)49 and expressed in the Escherichia coli BL21 (DE3)
Gold pLysS strain. E.coli cells were lysed by sonication in 50mM Tris-HCL pH 7.5,
150mM NaCl, 5mM b-mercaptoethanol and 10% glycerol. The lysates were
incubated with BSA-blocked Ni2þ–NTA or GSH beads for 1 h followed by three
washes with lysis buffer. Bound material was eluted in lysis buffer supplemented
with 500mM imidazole (Ni2þ–NTA beads) or 30mM reduced glutathione
(GSH-beads). Large-scale purification of the MmIFT54 CH-domain included the
additional steps (after affinity-tag cleavage using tobacco etch virus protease) of
anion-exchange chromatography (MonoQ, GE healthcare) and size exclusion
chromatography (HiLoad75, GE healthcare) in 10mM HEPES pH 7.5, 150mM
NaCl and 1mM DTT. All samples were analysed using SDS–PAGE.
For heterodimeric IFT54/20 complex purification, full-length CrIFT54 (WT or
point mutants) and CrIFT20 were cloned either untagged or with tobacco etch
virus-cleavable HIS-tag into pFL vectors. After producing viral particles by
transfection of Sf21 insect cells using CellFectin (Life Technologies), IFT20/54
(WT or V126A/M) were expressed by infection of HighFive insect cells
(Life Technologies)49. The cells were homogenized using a Dounce Homogenizer
in a 20mM HEPES pH 7.5 buffer containing 250mM sucrose, 5mM
b-mercaptoethanol, 10mM KCl, 1.5mM MgCl2 and protease inhibitor cocktail
(Roche) and then purified in large scale as described above.
Circular dichroism spectroscopy. Secondary structure content was analysed on a
Jasco J-715 spectropolarimeter at 4 C using 0.1mgml 1 of recombinant purified
proteins in a 0.1-cm quartz cuvette. The measurements were performed in 10mM
HEPES 7.5, 100mM NaCl, 10% glycerol and 5mM DTT. Data were obtained and
processed using the Spectra Manager v2.06 software from Jasco. The measured
curves were buffer corrected and secondary structure assignments were done using
the CONTIN fitting method and SMP56 as the reference protein set. Melting
curves were measured continuously from 10 to 90 C, with additional full spectra
taken in 10 C steps. Data analysis was performed in Spectra Manager v2.06.
Zebrafish strains and morpholinos. Adult zebrafish were maintained at 28 C, in
system water with a conductivity of 500 mS and a pH of 7. Embryos were cultured
at 28 C in embryo medium with 0.1% w/v methylene blue. The elipsa tp49d
mutant, which encodes a premature stop codon at position 195 (previously
described13) was obtained as a gift from J. Malicki. Heterozygous sibling
embryos were used as controls for all experiments using the elipsa mutant line.
An anti-sense morpholino targeting traf3ip1 (previously published13) was used for
knock-down experiments. Knock-down of map4 was performed using an ATG
translation-blocking morpholino (50-GGCATCACGTAAACTAAAGTCCATC-30)
and a 5-base-pair mismatch (50-GACATAACGTAAAATAAAATCAATC-30)
control, designed by and ordered from Genetools, LLC. Wild-type Tu¨:AB fish were
used for all morpholino experiments unless stated otherwise.
To rescue the elipsa/traf3ip1 knock-down phenotype, full-length zebrafish
ift54 coding sequence was amplified by reverese transcription PCR (RT–PCR).
Site-directed mutagenesis was then used to introduce mutations at the desired
locations. The resulting products were then cloned into the pGEM-T Easy vector
and constructs were linearized and transcribed using the SP6/T7 mMessage
mMachine kit (Ambion). Approximately 100 pg of mRNA was injected into
embryos at the 1-cell stage.
Effects of RNA injections (WT and mutated RNAs) were evaluated based on
severity of body curvature, analysis of pronephric cilia, presence or absence of
pronephric cysts and surface area of the retina. Body curvature was quantified by
measuring the internal angle of each larva using ImageJ software. Larvae were
classified as follows: severe (0–60); moderate (60–90); mild (90–120); and
normal (over 120). Live embryos and larvae were photographed using a Leica
M165FC microscope and camera. For histological analysis, larvae were fixed in 4%
paraformaldehyde (PFA, Electron Microscopy Sciences), embedded in paraffin and
sectioned at 5 mm. Sections were stained with haematoxylin and eosin (H&E) and
photographed with a Nikon DXM1200F camera and an Olympus BX41
microscope.
Plasmids and establishment of stable cell lines. MmFlag-Traf3ip1 construct was
a gift from G. Pazour20. Human cDNA of TRAF3IP1 (Invitrogen) was cloned into
the pcDNA–DEST40 vector. The mutations were created using the QuickChange
site-directed mutagenesis kit according to the manufacturers protocol (Stratagene).
For gene silencing of TRAF3IP1, the shRNA sequences described in Supplementary
Table 3 were cloned into the lentiviral pLKO.1 vector that contained a cassette
conferring puromycin resistance. mIMCD3 (from ATCC) were transduced with
non-targeted (shNTC) or Traf3ip1-specific shRNA sequences and selected by
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adding puromycin (Sigma, 2 mgml 1) to the culture medium (DMEM/F12(1:1)
with GlutaMaxI medium containing 10% fetal bovine serum (FBS), 100Uml 1
penicillin and 100mgml 1 streptomycin (all from Life technologies). For rescue
experiments, shNTC and shTraf3ip1(shRNA #461) mIMCD3 cells were transfected
with pDEST40-GFP-TRAF3IP1-WT or mutant plasmids using Amaxa Cell Line
Nucleofector (Solution V, program O17, Lonza)50, sorted by FACS and selected
with 0.35mg/ml G418 (Life Technologies). shNTC and Traf3ip1-KD cells
expressing either GFP or GFP-IFT54 mutants were re-transduced with control or
Map4 shRNA sequences (MSH027680-LVRH1GH, GeneCopeia) and selected with
200mg/ml hygromycin B (Life Tehnologies). Fibroblasts were obtained from skin
biopsies of patients and cultured in Optimem supplemented with 10% FBS,
100Uml 1 penicillin and 100mgml 1 streptomycin (all from Life Technologies).
Fibroblasts were then cultured up to 10 passages. Ciliogenesis was induced by
starving the cells in serum-free Optimem for 24 h. HEK293T cells (from ATCC)
were cultured in DMEM supplemented with 10% FBS, 100Uml 1 penicillin and
100mgml 1 streptomycin.
Antibodies. The following antibodies were used in the study: acetylated a-tubulin
(6–11-B-1, used at 1:10,000 to detect cilia and 1:1,000 to detect cytoplasmic
microtubules) and a-tubulin (T5168, used at 1:1,000 for immunofluorescence (IF)
and 1:50,000 for western blot) from Sigma; EB1 (610534, used at 1:200),
b-catenin (610153, used at 1:200) and anti-PKAc (610980, used at 1:200) from BD
biosciences; acetylated a-tubulin (ab24610, used at 1:500) and a-tubulin (ab18251,
used at 1:500) from Abcam; IFT54 (HPA037858, Atlas Antibodies, used at 1:50 for
IF and 1:1,000 for WB); ZO1 (61–7300, used at 1:100) from Life Technologies;
ARL13B (17711-1-AP, Proteintech, used at 1:400); Gp135 (AF1556, R&D, used at
1:200 for IF and 1:1000 for WB); g-tubulin (DQ-19, Sigma, used at 1:500);
g-tubulin (C-20, used at 1:200), MAP4 (H-300 and G-10, used at 1:400 for IF and
1:1,000 for WB) and ACIII (C-20, used at 1:200) from Santa Cruz; GAPDH
(MAB374, used at 1:4000 for WB) from Millipore. Highly cross adsorbed sec-
ondary antibodies (Alexa Fluor 488, Alexa Fluor 546, AlexaFluor 555, AlexaFluor
532 and Alexa Fluor 647) were obtained from Molecular Probes (Life Technolo-
gies) and were used at 1:200 dilution.
Immunofluorescence and image analysis. Zebrafish embryos at 48 hpf were
fixed overnight at 4 C in 4% PFA, washed in PBS (Sigma) and incubated in PBS-
Triton-4% BSA (Sigma) for 1 h at 4 C before antibody incubation. Alternatively,
fibroblasts and mIMCD3 cells were fixed in 4% PFA, permeabilized with 0.2%
Triton-X 100 or fixed in ice-cold Methanol for 5min and incubated with 1% skim
milk or 1% BSA, 0.1% Tween20 before incubation with primary (1–3 h at room
temperature or overnight at 4 C) and secondary (30min at room temperature)
antibodies. Appropriate controls were performed omitting the primary antibodies.
DNA was stained with Dapi or Hoechst (Life Technologies) (except for STED
imaging). Confocal images were taken on either Zeiss LSM 700 or LEICA SP8
microscopes. Images were analysed with ImageJ. Alternatively, super resolution
images were acquired using a LEICA SP8 gSTED microcoscope, equipped with a
660-nm laser that quenches the fluorescence outside the centre of the focus. Images
were then deconvoluted using Huygens software. Ciliogenesis analyses were
performed on a CV7000 confocal microscope from YOKOGAWA with  40 long
distance. Z-stacks were acquired with identical acquisition settings (gain, offset,
laser power) and all measurements of fluorescence intensity were performed on
maximum intensity projection, calculated with the Yokogawa software. For all cilia
numerical values (frequency, length), we developed one specific pipeline using
CellProfiler software51. In brief, nuclei were detected as primary objects using Otsu
Adaptive two-class thresholding. For cilia length, a mask was constructed by
applying MoG global thresholding on ARL13B staining, followed by measurement
of the major axis length. Cilia frequency was calculated by dividing cilia and nuclei
counts. All data points are performed in duplicate with four fields acquired per
well, and an average of 300 cells per field. Cell profiler pipeline was run using the
Linux cluster interface JENKINS. Spheroids were directly analysed using the ZEN
2011 software (Zeiss).
Calcium switch assay and TER measurement. mIMCD3 cells grown on 65-mm
Transwell filters (Corning) for 7 days were subjected to Ca2þ switch as described
in Straight et al.52 Briefly, cells were washed with PBS-4mM EGTA and Ca2þ free
DMEM (Life Technologies) containing 4mM EGTA was added to the cells for
45min to disrupt cell junctions. Cells were then washed twice with normal culture
medium (DMEM/F12) and TER was determined using a Millicell-ERS volt-ohm
meter (Millipore) immediately after the addition of normal growth medium and at
the indicated time points. Six hours after Ca2þ switch, cells were fixed with 4%
PFA and processed as described above.
Spheroid assay. Three-dimensional spheroid cell culture was performed using 5%
Matrigel (BD) in chamber slides (Lab-TEK). Ten thousand cells were plated per
chamber and spheroids were grown at 37 C/5% CO2 for 5 days. Spheroids were
fixed with 1% PFA, further stained and analysed as described in ‘immuno-
fluorescence analysis’.
Protein extraction and western blotting. Cells were extracted in 50mM
Tris-HCl, 150mM NaCl, 0.5% sodium deoxycholate, 2mM EDTA, 1% Triton
X-100, 0.1% sodium dodecyl sulfate and protease inhibitor cocktail (Roche). Pro-
tein quantification was then performed using the BCA protein assay kit (Ther-
moScientific). A measure of 30–50 mg of proteins were loaded on 8 or 10%
acrylamide gels, blotted on PVDF membrane (Millipore) and the membrane was
incubated using the indicated antibodies. Western blots were then analysed with
Bioprofil software.
qPCR. Total cellular mRNA was isolated using Qiagen Extraction Kit and treated
with DNase I. 1 mg of total RNA was reverse-transcribed using Superscript II
(Life Technologies). Relative expression levels of the TRAF3IP1 or MAP4 mRNAs
were determined by real-time PCR using either Absolute SYBR Green ROX Mix
(ABgene) or TaqMan Gene Expression Assay (Applied Biosystems) with specific
primers (Supplementary Table 3). HhTRAF3IP1, HhMAP4, MmTraf3ip1
(Mm01285632_m1, Life Technologies) expression performed in triplicate was
normalized to HhGAPDH or MmTbp (Mm00446971_m1, Life Technologies)
mRNA expression. Data were analysed with the 2DDCt method30.
Co-immunoprecipitation. HEK 293T cells were co-transfected with Flag-tagged
MmTraf3ip1 constructs and GFP–MmIft20 (kindly given by G. Pazour) or
GFP-MmMap4 (gift from J. Nelson) using the calcium phosphate method.
Forty-eight hours post transfection, cells were lysed in 50mM Tris-HCl pH 7.5,
150mM NaCl, 0.5% Triton and lysates were first incubated with rabbit or mouse
isotypic control antibodies and G-protein beads (Sigma) for 1 h at 4 C. Precleared
lysates (containing 1mg of proteins) were then incubated with rabbit anti-Flag
(Sigma) or mouse monoclonal anti-GFP antibodies (Roche) coupled to G-protein
beads for 3 h at 4 C. Beads were then washed three times with increasing amounts
of NaCl (150 nM; 300 nM and 600 nM NaCl in 50mM Tris-HCl pH 7.5),
resuspended in 2 sample buffer (Sigma) and boiled for 5min. Western blot
analyses were conducted as described above.
Microtubule tracking. EB3–GFP plasmid (obtained from R. Ko¨ster) was linear-
ized and reverse transcribed using the SP6 mMessage mMachine kit (Ambion).
Elipsa embryos were then injected with 50 pg of EB3-GFP RNA at the 1-cell stage,
and photographed at 60 hpf. Time-lapse confocal microscopy images were
recorded over a period of 5min, and the resulting sequences were analysed using
Imaris software to quantify the microtubule dynamics in vivo.
Statistical analyses. Results are presented as means of at least n¼ 2 independent
experiments±s.e./s.d. Statistical analyses were performed with the GraphPad
Prism software by using ANOVA followed by Bonferonni’s or Dunnett’s multiple-
comparisons test versus a control group (post hoc) or by using Kruskal–Wallis test
followed by Dunn’s multiple comparisons post hoc test. Po0.05 was considered
statistically significant.
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